- Home
- NATR vs GNFT Comparison
NATR vs GNFT Comparison
Compare NATR & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATR
- GNFT
- Stock Information
- Founded
- NATR 1972
- GNFT 1999
- Country
- NATR United States
- GNFT France
- Employees
- NATR N/A
- GNFT N/A
- Industry
- NATR Biotechnology: Pharmaceutical Preparations
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NATR Health Care
- GNFT Health Care
- Exchange
- NATR Nasdaq
- GNFT Nasdaq
- Market Cap
- NATR 297.2M
- GNFT 216.7M
- IPO Year
- NATR N/A
- GNFT 2019
- Fundamental
- Price
- NATR $16.56
- GNFT $4.24
- Analyst Decision
- NATR Strong Buy
- GNFT Strong Buy
- Analyst Count
- NATR 2
- GNFT 2
- Target Price
- NATR $20.50
- GNFT $11.00
- AVG Volume (30 Days)
- NATR 98.1K
- GNFT 2.8K
- Earning Date
- NATR 11-06-2025
- GNFT 09-22-2025
- Dividend Yield
- NATR N/A
- GNFT N/A
- EPS Growth
- NATR N/A
- GNFT N/A
- EPS
- NATR 0.75
- GNFT 0.03
- Revenue
- NATR $460,818,000.00
- GNFT $73,187,701.00
- Revenue This Year
- NATR $4.88
- GNFT $5.44
- Revenue Next Year
- NATR $2.66
- GNFT N/A
- P/E Ratio
- NATR $22.49
- GNFT $135.62
- Revenue Growth
- NATR 4.33
- GNFT 105.01
- 52 Week Low
- NATR $11.01
- GNFT $2.55
- 52 Week High
- NATR $18.06
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- NATR 48.93
- GNFT 54.90
- Support Level
- NATR $16.75
- GNFT $4.10
- Resistance Level
- NATR $17.10
- GNFT $4.35
- Average True Range (ATR)
- NATR 0.44
- GNFT 0.11
- MACD
- NATR -0.12
- GNFT 0.02
- Stochastic Oscillator
- NATR 12.90
- GNFT 78.90
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.